Key facts
- It has raised $15.5M; the latest was Early Stage VC ($14.0M) in Oct 2025.
- Notable investors include QF Capital, China Taiping Insurance (UK) Company, Changjiang Capital Co., Ltd, Shenzhen Lihe Yingfei Venture Capital — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for WYTD
- ·The full record, as it builds
Funding rounds
No funding rounds for WYTD are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About WYTD
Developer and manufacturer of minimally invasive surgical medical devices intended for interventional treatment of structural heart disease. The company's products mainly include automatic cardiac shunt diagnostic equipment, super-compliant balloons, degradable occlusion systems and so on, targeting the treatment of patent foramen ovale (PFO), enabling medical industry users to improve diagnostic efficiency and reduce surgical risks.
- Sector
- Healthcare
- HQ
- Shenzhen, China
- Founded
- 2021
- Employees
- 26
- Website
- en.wytd.com/
- Ownership
- Privately Held (backing)
WYTD doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in WYTD shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on WYTD in its N-PORT filings yet. We sweep new filings monthly.